Sagespring Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.61M Buy
18,256
+246
+1% +$84.2K 0.1% 112
2026
Q1
$6.34M Buy
18,010
+2,285
+15% +$815K 0.12% 101
2025
Q4
$5.15M Buy
15,725
+1,671
+12% +$530K 0.09% 108
2025
Q3
$3.97M Buy
14,054
+438
+3% +$127K 0.08% 125
2025
Q2
$3.8M Buy
13,616
+1,454
+12% +$412K 0.08% 124
2025
Q1
$3.79M Sell
12,162
-2,343
-16% -$692K 0.1% 111
2024
Q4
$3.78M Buy
+14,505
New +$4.3M 0.1% 99

Other funds holding AMGN

Sagespring Wealth Partners's AMGN Position: Q2 2026 in Review

Sagespring Wealth Partners increased its Amgen (AMGN) stake by 1.4% in Q2 2026, buying an estimated $84.2K and bringing the position to 18,256 shares worth $6.61M. The position accounts for 0.1% of the portfolio, ranked #112.

Sagespring Wealth Partners first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sagespring Wealth Partners held 18,256 shares of Amgen worth $6.61M as of Q2 2026.
  • Sagespring Wealth Partners bought 246 Amgen shares in Q2 2026, an estimated $84.2K.
  • Amgen made up 0.1% of Sagespring Wealth Partners's portfolio in Q2 2026, its #112 holding.
  • Sagespring Wealth Partners first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.